Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001415889-24-007534 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-11 | 2024-03-07+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +25.9K | 5,393 | New | +$55.5K |
| DM | 2024-03-11 | 2024-03-07+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -25.9K | 1,960 | -93% | -$649.2K |
| DM | 2024-03-11 | 2024-03-07+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $0.00 | -25.9K | 55.3K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | M | A | 114 | $2.14 | 2,074 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-11 | S | D | 3,423 | $25.24 | 1,970 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.88, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2024-03-07 | M | A | 22,386 | $2.14 | 24,346 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-07 | S | D | 22,386 | $25.00 | 1,960 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.289, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2024-03-11 | S | D | 10 | $26.31 | 1,960 | D | — | — | |
| 6 | Common | Common Stock | 2024-03-11 | M | A | 3,433 | $2.14 | 5,393 | D | — | — | |
| 7 | Common | Common Stock | 2024-03-08 | S | D | 114 | $25.00 | 1,960 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-03-07 | M | D | 1,400 | $0.00 | 28,263 | D | $2.14 · — to 2031-04-01 | 1,400 Common Stock | (F4) A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-03-07 | M | D | 20,986 | $0.00 | 58,877 | D | $2.14 · — to 2031-04-01 | 20,986 Common Stock | (F5) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2024-03-08 | M | D | 114 | $0.00 | 58,763 | D | $2.14 · — to 2031-04-01 | 114 Common Stock | (F5) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 11 | Derivative | Stock Option (Right to Buy) | 2024-03-11 | M | D | 3,433 | $0.00 | 55,330 | D | $2.14 · — to 2031-04-01 | 3,433 Common Stock | (F5) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |